Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
ZymoGenetics CEO Bruce Carter Retires, Promotes Doug Williams, Says Sad Goodbyes to Biotech “Family”
|
Luke Timmerman |
11/21/08 |
|
Seattle
|
|
Biotech Survival Index: Cash Running Low at Seattle Life Sciences Companies
|
Luke Timmerman |
11/13/08 |
|
Seattle
|
|
Tysabri’s Roots at the “Hutch,” MediQuest Spurned by FDA, ZymoGenetics Drug Passes Test, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/06/08 |
|
Seattle
|
|
ZymoGenetics Cash Gets Lean, Recothrom Sales Still Slow
|
Luke Timmerman |
11/04/08 |
|
Seattle
|
|
ZymoGenetics Trial Halted, Amgen’s Big New Drug, Spiration Gets FDA Nod, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/30/08 |
|
Seattle
|
|
Amazon Gets Into Games, Getty Grabs Jupiterimages, ZymoGenetics Settles a Suit, & More Seattle-Area Deals News
|
Gregory T. Huang |
10/28/08 |
|
Seattle
|
|
ZymoGenetics Drug Trial Halted Because of Infection Risk
|
Luke Timmerman |
10/27/08 |
|
Seattle
|
|
ZymoGenetics Gets $21M From Bristol-Myers To Settle Patent Suit
|
Luke Timmerman |
10/23/08 |
|
Seattle
|
|
Merck Bails on Seattle, Gates Foundation Backs Far-Out Ideas, Zymo Drug Shows Promise & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/23/08 |
|
Seattle
|
|
ZymoGenetics’ Kidney Cancer Drug, Taken with Nexavar, Shrinks Tumors in Relapsed Patients
|
Luke Timmerman |
10/22/08 |
|
Seattle
|
|
ZymoGenetics “Sleeper” Wakes Up, Leroy Hood Unveils New Company, CMC Icos Expands, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/02/08 |
|
Seattle
|
|
ZymoGenetics “Sleeper” for Hepatitis C Aims to Wipe Out Side Effects of Anti-Viral Therapy
|
Luke Timmerman |
09/30/08 |
|
Seattle
|
|
Seattle Entrepreneurs Call Bay Area VCs, Amazon Sells XOs, Tableau Taps $10M, ZymoGenetics Gives Up Drug Rights, & More Deals News
|
Robert Buderi |
09/09/08 |
|
Seattle
|
|
Seattle Genetics’ Medical Point Man, Tom Reynolds, Aims to Capitalize on Hodgkin’s Drug
|
Luke Timmerman |
09/08/08 |
|
Seattle
|
|
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA
|
Luke Timmerman |
09/03/08 |
|
Seattle
|
|
ZymoGenetics, Bayer Drug Vying for European Regulatory Approval
|
Luke Timmerman |
09/02/08 |
|
Seattle
|
|
ZymoGenetics Sells Land for $11.5 Million
|
Luke Timmerman |
08/29/08 |
|
Seattle
|
|
Putting Electrons Behind Getting Things Built: Seattle Science Foundation Aims to Connect Scientists, Start Companies
|
Luke Timmerman |
08/22/08 |
|
Seattle
|
|
ZymoGenetics Drug Getting Off to Slow Start in Marketplace
|
Luke Timmerman |
08/06/08 |
|
Seattle
|
|
Novo Nordisk Returning to Seattle, Hiring 80 People by 2010
|
Luke Timmerman |
08/05/08 |
|
Seattle
|
|
VLST Hires Paul Carter, Antibody Drug Expert, as New Chief Scientist
|
Luke Timmerman |
07/02/08 |
|
Seattle
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
